Shimizu H, Kuroki J, Ogura H, Yamanishi Y, Arakawa Y
Eisai Tsukuba Research Laboratories, Ibaraki, Japan.
Biomed Chromatogr. 1998 Jan-Feb;12(1):38-42. doi: 10.1002/(SICI)1099-0801(199801/02)12:1<38::AID-BMC724>3.0.CO;2-C.
We have developed a convenient method for the routine measurement of the absolute amount of nerve growth factor (NGF) mRNA in tissue samples. The method consists of RNA extraction, amplification by reverse transcription-PCR and detection by high-performance liquid chromatography. The addition of a deletion mutant RNA to tissue samples as an internal standard enabled correction for RNA recovery during extraction, and the target mRNA and the internal standard were both amplified with the same PCR primers. The conditions were optimized so that the procedure was conducted in the region where the calibration curve was linear, thereby allowing high reproducibility and reliability. The method was applied to the measurement of NGF mRNA in tissues such as skin and skeletal muscle, where the levels are too low to be easily detected by Northern blotting analysis: skin, 14.1 +/- 4.6 fg/mg tissue and skeletal muscle, 11.0 +/- 2.2 fg/mg tissue (mean +/- SD, n = 10). The coefficient of variation of this method was less than 2.8%. This approach should also be applicable to the routine assay of the absolute amount of other mRNAs present at low levels in tissues.
我们已经开发出一种便捷的方法,用于常规测量组织样本中神经生长因子(NGF)mRNA的绝对量。该方法包括RNA提取、逆转录聚合酶链反应(RT-PCR)扩增以及高效液相色谱检测。向组织样本中添加缺失突变体RNA作为内标,可对提取过程中的RNA回收率进行校正,并且靶mRNA和内标均使用相同的PCR引物进行扩增。对条件进行了优化,使得该程序在校准曲线呈线性的区域内进行,从而实现了高重现性和可靠性。该方法应用于皮肤和骨骼肌等组织中NGF mRNA的测量,这些组织中NGF mRNA的水平过低,难以通过Northern印迹分析轻易检测到:皮肤为14.1±4.6 fg/mg组织,骨骼肌为11.0±2.2 fg/mg组织(平均值±标准差,n = 10)。该方法的变异系数小于2.8%。这种方法也应该适用于对组织中低水平存在的其他mRNA的绝对量进行常规检测。